<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="2-part\PMC6920831\results\search\disease\results.xml">
  <result pre="to be more susceptible to viral infections such as during" exact="influenza" post="and dengue epidemics. We examined the co-factorial role of"/>
  <result pre="anti-inflammation and anti-obesity activity. persistent viral infection interferon lipid metabolism" exact="obesity" post="1. Viral Infectobesity: The Association of Chronic Viral Infections"/>
  <result pre="Infections with Obesity According to recent statistics, the prevalence of" exact="obesity" post="was 39.8% and affected about 93.3 million US adults"/>
  <result pre="2015~2016 [1]. Similarly, in many other countries worldwide, overweight and" exact="obesity" post="are also dramatically on the rise, particularly in urban"/>
  <result pre="the rise, particularly in urban areas [2]. We face an" exact="obesity" post="epidemic that has a complex and multifactorial etiology [3]."/>
  <result pre="epidemic that has a complex and multifactorial etiology [3]. While" exact="obesity" post="is multifactorial, a simplified thermo-dynamic model, rather than a"/>
  <result pre="thermo-dynamic model, rather than a biological model, has prevailed in" exact="obesity" post="clinics for over 90 years [3]. A key suggestion"/>
  <result pre="calorie intake and exercise more. While addressing proximate causes of" exact="obesity" post="serves as a global health priority, it seems incomplete"/>
  <result pre="global health priority, it seems incomplete or ineffective to control" exact="obesity" post="given that the epidemic has continued to worsen at"/>
  <result pre="obesity. In this regard, we review the biological complex of" exact="obesity" post="and interpret its etiology from the interaction between immune"/>
  <result pre="fundamental requirements and are highly inter-dependent for species survival. Sequentially," exact="obesity" post="displays itself as a metabolic overload (shown by excess"/>
  <result pre="overload (shown by excess adipose tissue) in addition to an" exact="immune disorder," post="which accompanies a low-grade inflammatory state known as &quot;meta-inflammation�?"/>
  <result pre="pathogenic persistence [4,11,12,13,14]. In this context, recent studies have associated" exact="obesity" post="with numerous microbial agents in both humans and animal"/>
  <result pre="we recap the evidence of viral agents in association with" exact="obesity" post="and relevant metabolic syndrome [13,14,15,16,17]. In addition to examination"/>
  <result pre="evidence of viral agents in association with obesity and relevant" exact="metabolic syndrome" post="[13,14,15,16,17]. In addition to examination of the major viruses"/>
  <result pre="biochemical mechanism to understand the interaction of viral infection and" exact="obesity" post="[4,5,11,19]. As shown in Table 1, the major viruses"/>
  <result pre="the major viruses and VLA that have been associated with" exact="obesity" post="in both humans and animal models include members of"/>
  <result pre="obesity-associated immune suppression. This, in turn, underlies reciprocal causality between" exact="obesity" post="and higher susceptibility of obese individuals to viral infections"/>
  <result pre="and several serotypes of human Ad have been associated with" exact="obesity" post="regarding epidemiological correlation in certain subsets of humans and"/>
  <result pre="-9, 31, -36, and -37 have been observed to cause" exact="obesity" post="at different levels. First, these five Ad serotypes induced"/>
  <result pre="and marmosets (Ad-36). Third, Ad-5 has been associated with child" exact="obesity" post="and Ad-36 in both adults and children [15,24]. Mechanistically,"/>
  <result pre="VLA listed in Table 1 have also been associated with" exact="obesity" post="in animals and humans through pathological studies or epidemiological"/>
  <result pre="[11,12,46,47,48,49]. Such as in mice infected by norovirus (MNV) and" exact="lymphocytic choriomeningitis" post="virus (LCMV), IFN-α/β played a systemic role in control"/>
  <result pre="partly, the immune dysfunction [11,12] that triggers metabolic disorders and" exact="obesity" post="(Table 1) [4,13,14,15,16,17,63]. 3. Gut Microbiota and Intrinsic Interferon"/>
  <result pre="Response Current studies link gut microbiota to the development of" exact="obesity" post="and its related comorbidities in the following aspects [64,65,66,67]."/>
  <result pre="with obesity. The association of some bacterial taxonomic groups with" exact="obesity" post="and relevant comorbidities was observed such as lower content"/>
  <result pre="the disorder of gut microflora could be a drive to" exact="obesity" post="development. Second, germ-free (GF) animal models provide eloquent evidence"/>
  <result pre="eloquent evidence to address the role of gut microbiota in" exact="obesity" post="induction. Without gut microbiota colonization, GF mice were highly"/>
  <result pre="Without gut microbiota colonization, GF mice were highly resistant to" exact="obesity" post="induced by a high-fat diet than normal mice despite"/>
  <result pre="and cholesterol in young mice [64,65,66,67]. Mechanistically, gut microbiota affect" exact="obesity" post="development in an inter-systemic manner. Locally in the gut,"/>
  <result pre="of eukaryotic viruses and bacterial phages. While phages potentially affect" exact="obesity" post="indirectly through modulating bacterial composition, eukaryotic viruses can directly"/>
  <result pre="is a missing link underlying human diseases like cancers and" exact="obesity" post="[68,69,71]. Further studies are needed to decipher the composition"/>
  <result pre="lack of studies to correlate certain viral taxonomic groups with" exact="obesity" post="in humans and animals, they may have an overlapping"/>
  <result pre="have an overlapping spectrum with most persistent viruses associated with" exact="obesity" post="(Table 1) [13,14,15,16,17,68,69,70,71]. Evolutionarily, the IFN system represents a"/>
  <result pre="anti-inflammatory microenvironment, which buffers a homeostatic resistance to meta-inflammation in" exact="obesity" post="(Figure 1) [76,77,78]. Using hydrodynamic gene transfer to increase"/>
  <result pre="cellular immune responses and was recently shown to directly inactivate" exact="influenza" post="virus replication [87]. On the other hand, viral infections"/>
  <result pre="human cells including macrophages, DCs, T cells, keratinocytes, and some" exact="cancer" post="cell lines [18,80,81,91,92,93,94]. Particularly in macrophages, IFNs also act"/>
  <result pre="the cell antimicrobial activity against engulfed pathogens [82,89,95,96,97,98]. The IFN" exact="suppression" post="of lipid metabolism is multifaceted, and can occur by"/>
  <result pre="and obesity, and molecular manipulation of body ceramide to control" exact="obesity" post="was illuminated by a recent elegant study [104]. Notably,"/>
  <result pre="might be an adipogenic drive and could lead to immune" exact="suppression" post="mostly in obesity patients (see Figure 3 and the"/>
  <result pre="adipogenic drive and could lead to immune suppression mostly in" exact="obesity" post="patients (see Figure 3 and the next section) [80,81]."/>
  <result pre="Causality of Obesity and Persistent Viral Infections The association of" exact="obesity" post="with various viral infections has always faced a &quot;chicken"/>
  <result pre="[13,14,15,16,17]. Do viral infections trigger the infectobesity first, or does" exact="obesity" post="lead to higher susceptibility to viral infections that manifest"/>
  <result pre="above, we reinforced the reciprocal causality of viral infections and" exact="obesity" post="underlying the infectobesity [14]. First, multiple viruses and VLAs"/>
  <result pre="First, multiple viruses and VLAs have been epidemiologically associated with" exact="obesity" post="and some with identified mechanisms in adipogenic or lipogenic"/>
  <result pre="obesogenesis and complicate into infectobesity [4,7,64,66]. On the other hand," exact="obesity" post="also provokes an aberration in the immune system including"/>
  <result pre="relevant to T cells and B cells in people with" exact="obesity" post="[4,14,19,77,106]. IFN signaling occurs via the same JAK–STAT pathway"/>
  <result pre="obese patients, showing that basal SOCS-3 expression was increased in" exact="obesity" post="and correlated to the reduction of type I IFN"/>
  <result pre="infections [5,108]. More severe lung inflammation and lung damage from" exact="viral pneumonia" post="as well as prolonged viral shedding were observed in"/>
  <result pre="[5,108]. More severe lung inflammation and lung damage from viral" exact="pneumonia" post="as well as prolonged viral shedding were observed in"/>
  <result pre="be among the risk factors for severe outcomes in pandemic" exact="influenza" post="infection [5,14,108]. In one report, the incidence of DENV"/>
  <result pre="that persistent viral infection and perturbation of IFN signaling exacerbate" exact="obesity" post="development. Regarding systemic interaction in animal and human bodies,"/>
  <result pre="persistent viral infections and underlie the systemic inflammation observed in" exact="obesity" post="[4,11,12,13,14,15,16,17]. A recent study by Ghazarian et al. (2017)"/>
  <result pre="correlates with insulin resistance in obesity-linked fat liver (termed nonalcoholic" exact="fatty liver disease," post="NAFLD) in obese patients [107]. This study also critically"/>
  <result pre="with insulin resistance in obesity-linked fat liver (termed nonalcoholic fatty" exact="liver disease," post="NAFLD) in obese patients [107]. This study also critically"/>
  <result pre="[107]. It is likely that the dysbiotic microbiome in the" exact="obesity" post="and NAFLD patients may harbor persistent infections. In turn,"/>
  <result pre="of long-chain fatty acid (LFA) and leptin by expanding adipocytes," exact="obesity" post="is accompanied with general immune suppression including aberration of"/>
  <result pre="leptin by expanding adipocytes, obesity is accompanied with general immune" exact="suppression" post="including aberration of antiviral IFN signaling, which leads to"/>
  <result pre="infections (Figure 3) [4,11,48,107,109]. Therefore, in most cases of infectobesity," exact="obesity" post="and viral infections may interact dynamically as a reciprocal"/>
  <result pre="The emerging theme of IFNs as a critical regulator of" exact="obesity" post="has been demonstrated by several reports targeting therapeutic development"/>
  <result pre="has been demonstrated by several reports targeting therapeutic development against" exact="obesity" post="in both cell and animal models. McGillicuddy et al."/>
  <result pre="adipose tissue, but not hepatocyte-specific deletion of Ifnar1 worsened HFD-induced" exact="metabolic syndrome." post="Conversely, improved metabolic control in laparoscopic adjustable gastric banding"/>
  <result pre="improved metabolic control in laparoscopic adjustable gastric banding patients with" exact="obesity" post="was associated with stimulation of type I IFN-regulated genes"/>
  <result pre="(particularly adipocytes/hepatocytes) that are closely relevant to the development of" exact="obesity" post="and metabolic disorders [111]. Again, using hydrodynamic gene transfer"/>
  <result pre="that targeting IFN signaling represents a promising strategy to block" exact="obesity" post="development and its related pathologies. So, how about other"/>
  <result pre="may provide more IFN-based options for therapeutic optimization against current" exact="obesity" post="prevalence and reveal IFN subtypes that bear superior activity"/>
  <result pre="with IFN signaling provides another rationale to associate IFNs with" exact="obesity" post="[29,48]. However, more direct evidence such as using IFN-signaling"/>
  <result pre="if and how fundamental IFN signaling plays a role in" exact="obesity" post="development. Remarkably, all immune responses are a double-edged sword,"/>
  <result pre="cause of overeating?JAMA20143112167216810.1001/jama.2014.413324839118 4.HotamisligilG.S.Inflammation, metaflammation and immunometabolic disordersNature201754217718510.1038/nature2136328179656 5.HonceR.Schultz-CherryS.Impact of" exact="obesity" post="on influenza A virus pathogenesis, immune response, and evolutionFront"/>
  <result pre="overeating?JAMA20143112167216810.1001/jama.2014.413324839118 4.HotamisligilG.S.Inflammation, metaflammation and immunometabolic disordersNature201754217718510.1038/nature2136328179656 5.HonceR.Schultz-CherryS.Impact of obesity on" exact="influenza" post="A virus pathogenesis, immune response, and evolutionFront Immunol.201910107110.3389/fimmu.2019.0107131134099 6.PrevedenT.ScarpelliniE.MilićN.LuzzaF.AbenavoliL.Gut"/>
  <result pre="immune response, and evolutionFront Immunol.201910107110.3389/fimmu.2019.0107131134099 6.PrevedenT.ScarpelliniE.MilićN.LuzzaF.AbenavoliL.Gut microbiota changes and chronic" exact="hepatitis" post="C virus infectionExpert Rev. Gastroenterol. Hepatol.20171181381910.1080/17474124.2017.134366328621554 7.ManS.M.Inflammasomes in the"/>
  <result pre="infectionExpert Rev. Gastroenterol. Hepatol.20171181381910.1080/17474124.2017.134366328621554 7.ManS.M.Inflammasomes in the gastrointestinal tract: Infection," exact="cancer" post="and gut microbiota homeostasisNat. Rev. Gastroenterol. Hepatol.20181572173710.1038/s41575-018-0054-130185915 8.DebédatJ.ClémentK.Aron-WisnewskyJ.Gut Microbiota"/>
  <result pre="norovirus persistence despite enhanced adaptive immunityPLoS Pathog.201612e100568410.1371/journal.ppat.100568427327515 20.TanV.P.K.NgimC.F.LeeE.Z.RamadasA.PongL.Y.NgJ.I.HassanS.S.NgX.Y.DhanoaA.The association between" exact="obesity" post="and dengue virus (DENV) infection in hospitalised patientsPLoS ONE201813e020069810.1371/journal.pone.020069830016369"/>
  <result pre="infection in hospitalised patientsPLoS ONE201813e020069810.1371/journal.pone.020069830016369 21.BadawiA.VelummailumR.RyooS.G.SenthinathanA.YaghoubiS.VasilevaD.OstermeierE.PlishkaM.SoosaipillaiM.AroraP.Prevalence of chronic comorbidities in" exact="dengue fever" post="and West Nile virus: A systematic review and meta-analysisPLoS"/>
  <result pre="HIV/AIDS Rep.20171421121910.1007/s11904-017-0368-629043609 23.LakeJ.E.StanleyT.L.ApovianC.M.BhasinS.BrownT.T.CapeauJ.CurrierJ.S.DubeM.P.FalutzJ.GrinspoonS.K.et al.Practical review of recognition and management of" exact="obesity" post="and lipohypertrophy in human immunodeficiency virus infectionClin. Infect. Dis.2017641422142910.1093/cid/cix17828329372"/>
  <result pre="of cellular metabolismVirology2015479–48060961810.1016/j.virol.2015.02.03825812764 31.RidauraV.K.FaithJ.J.ReyF.E.ChengJ.DuncanA.E.KauA.L.GriffinN.W.LombardV.HenrissatB.BainJ.R.et al.Gut microbiota from twins discordant for" exact="obesity" post="modulate metabolism in miceScience2013341125121410.1126/science.124121424009397 32.MillsS.ShanahanF.StantonC.HillC.CoffeyA.RossR.P.Movers and shakers: Influence of"/>
  <result pre="gain is mediated through shifts in the gut microbiome and" exact="suppression" post="of energy expenditureEBioMedicine201521725173410.1016/j.ebiom.2015.10.01826870798 34.GogokhiaL.BuhrkeK.BellR.HoffmanB.BrownD.G.Hanke-GogokhiaC.AjamiN.J.WongM.C.GhazaryanA.ValentineJ.F.et al.Expansion of bacteriophages is linked"/>
  <result pre="Endocrinol. Metab.20161011680168510.1210/jc.2015-420826863425 37.LiberskiP.P.GajosA.SikorskaB.LindenbaumS.Kuru, the first human prion diseaseViruses201911E23210.3390/v1103023230866511 38.KimY.S.CarpR.I.CallahanS.M.WisniewskiH.M.Scrapie induced" exact="obesity" post="in miceJ. Infect. Dis.198715640240510.1093/infdis/156.2.4023598239 39.CarpR.I.CallahanS.M.SersenE.A.MoretzR.C.Preclinical changes in weight of"/>
  <result pre="obesityProc. Soc. Exp. Biol. Med.1988189212710.3181/00379727-189-427743141932 41.StromA.YutzyB.KruipC.OomsM.SchlootN.C.RodenM.ScottF.W.LoewerJ.HolznagelE.Foodborne transmission of bovine spongiform" exact="encephalopathy" post="to non-human primates results in preclinical rapid-onset obesityPLoS ONE20149e10434310.1371/journal.pone.010434325090610"/>
  <result pre="resistance, and steatosisJ. Clin. Transl. Hepatol.20164667527047774 44.LazoM.NwankwoC.DayaN.R.ThomasD.L.MehtaS.H.JuraschekS.WillisK.SelvinE.Confluence of epidemics of" exact="hepatitis" post="C, diabetes, obesity, and chronic kidney disease in the"/>
  <result pre="Hepatol.20164667527047774 44.LazoM.NwankwoC.DayaN.R.ThomasD.L.MehtaS.H.JuraschekS.WillisK.SelvinE.Confluence of epidemics of hepatitis C, diabetes, obesity, and" exact="chronic kidney disease" post="in the United States populationClin. Gastroenterol. Hepatol.2017151957196410.1016/j.cgh.2017.04.04628579183 45.YenY.H.KeeK.M.ChenC.H.HuT.H.LuS.N.WangJ.H.HungC.H.Sustained virological"/>
  <result pre="risk factors are associated with mortality in patients with chronic" exact="hepatitis" post="CPLoS ONE201914e020885810.1371/journal.pone.020885830625158 46.ShieldsL.E.JenningsJ.LiuQ.LeeJ.MaW.BlechaF.MillerL.C.SangY.Cross-species genome-wide analysis reveals molecular and functional"/>
  <result pre="I interferon responsesNat. Rev. Immunol.201414364910.1038/nri358124362405 52.XieY.HeS.WangJ.MicroRNA-373 facilitates HSV-1 replication through" exact="suppression" post="of type I IFN response by targeting IRF1Biomed. Pharmacother.2018971409141610.1016/j.biopha.2017.11.07129156530"/>
  <result pre="IRF1Biomed. Pharmacother.2018971409141610.1016/j.biopha.2017.11.07129156530 53.RuJ.SunH.FanH.WangC.LiY.LiuM.TangH.MiR-23a facilitates the replication of HSV-1 through the" exact="suppression" post="of interferon regulatory factor 1PLoS ONE20149e11402110.1371/journal.pone.011402125461762 54.ClementM.MarsdenM.StaceyM.A.Abdul-KarimJ.GimenoBriasS.Costa BentoD.ScurrM.J.GhazalP.WeaverC.T.CarlessoG.et al.Cytomegalovirus-specific"/>
  <result pre="infection and slow disease progressionNature201451160160510.1038/nature1355425043006 60.ScagnolariC.MonteleoneK.CacciottiG.AntonelliG.Role of interferons in chronic" exact="hepatitis" post="C infectionCurr. Drug Targets20171884485010.2174/138945011766616020111263226844564 61.NanY.WuC.ZhangY.J.Interplay between Janus kinase/signal transducer"/>
  <result pre="physiology and diseaseNat. Med.2016221079108910.1038/nm.418527711063 65.MeijnikmanA.S.GerdesV.E.NieuwdorpM.HerremaH.Evaluating causality of gut microbiota in" exact="obesity" post="and diabetes in humansEndocr. Rev.20173913315310.1210/er.2017-0019229309555 66.SunL.MaL.MaY.ZhangF.ZhaoC.NieY.Insights into the role"/>
  <result pre="A multifaceted majorityFront. Microbiol.2015691810.3389/fmicb.2015.0091826441861 70.YadavH.JainS.NagpalR.MarottaF.Increased fecal viral content associated with" exact="obesity" post="in miceWorld J. Diabetes2016731632010.4239/wjd.v7.i15.31627555892 71.MukhopadhyaI.SegalJ.P.CardingS.R.HartA.L.HoldG.L.The gut virome: The ‘missing"/>
  <result pre="79.AlsaggarM.MillsM.LiuD.Interferon beta overexpression attenuates adipose tissue inflammation and high-fat diet-induced" exact="obesity" post="and maintains glucose homeostasisGene Ther.201724606610.1038/gt.2016.7627858942 80.FritschS.D.WeichhartT.Effects of interferons and"/>
  <result pre="activationNat. Immunol.20151683884910.1038/ni.320526147685 95.VlahosR.StambasJ.SelemidisS.Suppressing production of reactive oxygen species (ROS) for" exact="influenza" post="A virus therapyTrends Pharm. Sci.2012333810.1016/j.tips.2011.09.00121962460 96.WuT.MaF.MaX.JiaW.PanE.ChengG.ChenL.SunC.Regulating innate and adaptive"/>
  <result pre="steatosisScience201936538639210.1126/science.aav372231273070 105.OttenlingerF.M.MayerC.A.FerreirósN.SchreiberY.SchwiebsA.SchmidtK.G.AckermannH.PfeilschifterJ.M.RadekeH.H.Interferon-beta increases plasma ceramides of specific chain length in" exact="multiple sclerosis" post="patients, unlike fingolimod or natalizumabFront. Pharmacol.2016741210.3389/fphar.2016.0041227857690 106.O’SheaD.HoganA.E.Dysregulation of natural"/>
  <result pre="to non-obese mice during infection with the 2009 pandemic H1N1" exact="influenza" post="virusInfluenza Other Respir. Viruses2011541842510.1111/j.1750-2659.2011.00254.x21668672 109.WeberK.J.SauerM.HeL.TycksenE.KalugotlaG.RazaniB.SchillingJ.D.PPARγ deficiency suppresses the release"/>
  <result pre="Intrinsic interferon (IFN) response to microbiota tonic induction may suppress" exact="obesity" post="in addition to its role in potentiating rapid antiviral"/>
  <result pre="a general arrest of protein and lipid metabolism. The IFN" exact="suppression" post="of lipid metabolism is multifaceted such as directly repressing"/>
  <result pre="during acute phases of antiviral responses, is unlikely to induce" exact="obesity" post="and meta-inflammation underlying obesity; however, the prolonged IFN responses"/>
  <result pre="[80,81] with a permission. Figure 3 A reciprocal causality of" exact="obesity" post="and chronic viral infections. High-fat diet and viral infection"/>
  <result pre="of long-chain fatty acid (LFA) and leptin by expanding adipocytes," exact="obesity" post="is accompanied with meta-inflammation (enhanced by LFA) and susceptibility"/>
  <result pre="meta-inflammation (enhanced by LFA) and susceptibility to viral infections (through" exact="suppression" post="of IFN antiviral signaling by leptin induction of SOCS3"/>
  <result pre="chickens Obesity-association in humans Ad-5: childhood obesity, Ad-36: childhood, adult" exact="obesity" post="and BMISMAM-1: BMI Adipogenic gutmicrobe transferassociated with heavierhuman donor"/>
  <result pre="BMI Adipogenic gutmicrobe transferassociated with heavierhuman donor CMV: metabolicSyndromeHSV-1: adult" exact="obesity" post="Kuru obesity and/orbulimia duringearly disease inhumans HCV genotype 3:insulin"/>
  <result pre="gutmicrobe transferassociated with heavierhuman donor CMV: metabolicSyndromeHSV-1: adult obesity Kuru" exact="obesity" post="and/orbulimia duringearly disease inhumans HCV genotype 3:insulin resistance in"/>
  <result pre="disease inhumans HCV genotype 3:insulin resistance in humansDENV: children obesityHIV:" exact="obesity" post="in patients on ART Obesity during persistent viral infections?"/>
  <result pre="borna disease virus; BMI, body mass index; CMV, cytomegalovirus; DENV," exact="dengue fever" post="virus; HHV, human herpesvirus; HCV, hepatitis C virus; HSV-1,"/>
  <result pre="CMV, cytomegalovirus; DENV, dengue fever virus; HHV, human herpesvirus; HCV," exact="hepatitis" post="C virus; HSV-1, herpes simplex virus 1; IL, interleukin;"/>
  <result pre="fever virus; HHV, human herpesvirus; HCV, hepatitis C virus; HSV-1," exact="herpes simplex" post="virus 1; IL, interleukin; RAV, Rous-associated virus; SMAM, an"/>
 </snippets>
</snippetsTree>
